No data to show
XNYS
CON
Market cap2.66bUSD
Sep 17, Last price
20.78USD
1D
-2.90%
1Q
-0.48%
IPO
-9.10%
Name
Concentra Group Holdings Parent Inc
Chart & Performance
P/E
15.99
P/S
1.40
EPS
1.30
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
1.90b
+3.38%
Net income
167m
-7.45%
CFO
275m
+17.23%
Profile
Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. operates as a subsidiary of Select Medical Corporation.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY |
|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | |
| Income | ||||
Revenues | 1,900,192 3.38% | 1,838,081 6.60% | 1,724,359 -0.44% | |
Cost of revenue | 1,528,535 | 1,551,071 | 1,466,142 | |
Unusual Expense (Income) | ||||
NOPBT | 371,657 | 287,010 | 258,217 | |
NOPBT Margin | 19.56% | 15.61% | 14.97% | |
Operating Taxes | 59,496 | 40,263 | 52,653 | |
Tax Rate | 16.01% | 14.03% | 20.39% | |
NOPAT | 312,161 | 246,747 | 205,564 | |
Net income | 166,543 -7.45% | 179,947 7.93% | 166,727 -20.18% | |
Dividends | (1,543,642) | (6,130) | (6,289) | |
Dividend yield | 60.91% | |||
Proceeds from repurchase of equity | 495,795 | (25,710) | ||
BB yield | -19.56% | |||
| Debt | ||||
Debt current | 85,535 | 72,946 | 72,966 | |
Long-term debt | 2,338,187 | 1,260,857 | 966,680 | |
Deferred revenue | 2,967 | 154,211 | 332,769 | |
Other long-term liabilities | 24,043 | 181,733 | 25,018 | |
Net debt | 2,240,467 | 1,302,429 | 1,001,989 | |
| Cash flow | ||||
Cash from operating activities | 274,677 | 234,316 | 274,337 | |
CAPEX | (64,327) | (69,340) | (45,983) | |
Cash from investing activities | (71,265) | (75,308) | (50,927) | |
Cash from financing activities | (51,531) | (165,291) | (216,681) | |
FCF | 282,768 | 183,006 | (368,672) | |
| Balance | ||||
Cash | 183,255 | 31,374 | 37,657 | |
Long term investments | ||||
Excess cash | 88,245 | |||
Stockholders' equity | 37,887 | 1,177,439 | 996,115 | |
Invested Capital | 2,236,246 | 931,069 | 2,060,726 | |
ROIC | 19.71% | 16.49% | 9.98% | |
ROCE | 16.16% | 13.46% | 12.35% | |
| EV | ||||
Common stock shares outstanding | 128,126 | 126,594 | 126,594 | |
Price | 19.78 | |||
Market cap | 2,534,331 | |||
EV | 4,797,851 | |||
EBITDA | 438,835 | 360,061 | 331,884 | |
EV/EBITDA | 10.93 | |||
Interest | 69,694 | 114,039 | 32 | |
Interest/NOPBT | 18.75% | 39.73% | 0.01% | |